Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856232 · ClinicalTrials.gov registry record · NA
Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department
A NA study of Headache, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT00856232: Completed NA study of Headache, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00856232 is a NA study of Headache that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 91 participants, below the 153-participant average among 35 other Headache trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00856232, a NA study of Headache, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will randomly assign emergency department patients seeking treatment for a headache to one of three groups. The first group will receive standard emergency care as determined by the treating physician, the second group will breathe high flow air by facemask for 15 minutes, and the third group will breathe high flow oxygen by face mask for 15 minutes. The patients will be questioned in the beginning of their treatment and at 2, 5, 10, 15 and 30 minutes after it's begun about the intensity of their headache and how much relief they are experiencing from their treatment. Concentration of carbon dioxide exhaled by patients will also be recorded at 0, 2, 5, 10, 15 and 30 minutes. After fifteen minutes, the patients in groups 2 and 3 will continue with standard emergency care, which can include any treatment their physician sees fit. Patients in all three groups will receive a stopwatch in the beginning of their emergency department visit and record the total extent of time their headache will take to resolve.
Primary Outcome
Time to relief is a measure of time reported by a stopwatch the patients were provided in the beginning of the study, which showed elapsed time in minutes for patients to perceive that they no longer had a headache.
Conditions Studied
Interventions
- BIOLOGICAL Medical Air
- BIOLOGICAL Oxygen
Study Locations (1)
New Jersey
- Robert Wood Johnson University Hospital Emergency Department - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT00856232 record still lists
NCT00856232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 153-participant average among 35 other Headache trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Headache appearing as the primary indexed condition, and to 2 interventions - of which Medical Air is the first listed.
NCT00856232 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00856232 about?
NCT00856232 is a clinical study titled "Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department". This study will randomly assign emergency department patients seeking treatment for a headache to one of three groups. The first group will receive standard emergency care as determined by the treating physician, the second group will breathe high flow air by facemask for 15 minutes, and the third g...
What is the current status of trial NCT00856232?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2009-01. Estimated completion is 2011-05.
What conditions does trial NCT00856232 study?
This clinical trial studies the following conditions: Headache.
What interventions are being tested in trial NCT00856232?
The interventions under investigation include: Medical Air (BIOLOGICAL), Oxygen (BIOLOGICAL).
Who is sponsoring clinical trial NCT00856232?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00856232 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00856232's enrollment target sits among peer trials
91 17th of 35 higher than 19 of 35 other Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Placebo Impacts Sleep and Pain Modulation in Chronic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia